|
🐜
|
Active surveillance of small renal masses: progression patterns of early stage kidney cancer.
21 auth.
M. Jewett,
K. Mattar,
J. Basiuk,
C. Morash,
S. Pautler,
D. Siemens,
S. Tanguay,
R. Rendon,
M. Gleave,
D. Drachenberg,
...
R. Chow,
Hannah L. Chung,
J. Chin,
N. Fleshner,
A. Evans,
B. Gallie,
M. Haider,
J. Kachura,
G. Kurban,
K. Fernandes,
A. Finelli
|
8 |
2011 |
8
🐜
|
|
🐜
|
Outcomes of small renal mass needle core biopsy, nondiagnostic percutaneous biopsy, and the role of repeat biopsy.
8 auth.
M. Leveridge,
A. Finelli,
J. Kachura,
A. Evans,
Hannah L. Chung,
D. A. Shiff,
...
K. Fernandes,
M. Jewett
|
8 |
2011 |
8
🐜
|
|
🐬
|
Most renal oncocytomas appear to grow: observations of tumor kinetics with active surveillance.
S. Kawaguchi,
K. Fernandes,
A. Finelli,
M. Robinette,
N. Fleshner,
M. Jewett
|
6 |
2011 |
6
🐬
|
|
🐜
|
Comparison of risk calculators from the Prostate Cancer Prevention Trial and the European Randomized Study of Screening for Prostate Cancer in a contemporary Canadian cohort
12 auth.
G. Trottier,
M. Roobol,
N. Lawrentschuk,
P. Boström,
K. Fernandes,
A. Finelli,
...
K. Chadwick,
A. Evans,
T. H. van der Kwast,
A. Toi,
A. Zlotta,
N. Fleshner
|
6 |
2011 |
6
🐜
|
|
🐜
|
Barriers to immediate breast reconstruction in the Canadian universal health care system.
11 auth.
T. Zhong,
K. Fernandes,
R. Saskin,
R. Sutradhar,
J. Platt,
Brett Beber,
...
C. Novak,
D. McCready,
S. Hofer,
J. Irish,
N. Baxter
|
5 |
2014 |
5
🐜
|
|
🐜
|
Measurement of peri‐prostatic fat thickness using transrectal ultrasonography (TRUS): a new risk factor for prostate cancer
11 auth.
B. Bhindi,
G. Trottier,
M. Elharram,
K. Fernandes,
G. Lockwood,
A. Toi,
...
K. Hersey,
A. Finelli,
A. Evans,
T. H. van der Kwast,
N. Fleshner
|
5 |
2012 |
5
🐜
|
|
🐜
|
Geographic Variation Immediate and Delayed Breast Reconstruction Utilization in Ontario, Canada and Plastic Surgeon Availability: A Population-Based Observational Study
8 auth.
J. Platt,
T. Zhong,
R. Moineddin,
G. Booth,
A. Easson,
K. Fernandes,
...
P. Gozdyra,
N. Baxter
|
5 |
2015 |
5
🐜
|
|
🐬
|
Impact of Age at Diagnosis on Outcomes in Men with Castrate-Resistant Prostate Cancer (CRPC)
M. Humphreys,
K. Fernandes,
S. Sridhar
|
5 |
2013 |
5
🐬
|
|
🐬
|
Efficacy of a second line luteinizing hormone-releasing hormone agonist after advanced prostate cancer biochemical recurrence.
N. Lawrentschuk,
K. Fernandes,
D. Bell,
J. Barkin,
N. Fleshner
|
4 |
2011 |
4
🐬
|
|
🐜
|
Impact of Unrestricted Access to Pregabalin on the Use of Opioids and Other CNS-Active Medications: A Cross-Sectional Time Series Analysis
8 auth.
Herman Kwok,
W. Khuu,
K. Fernandes,
Diana Martins,
Mina Tadrous,
Samantha Singh,
...
D. Juurlink,
T. Gomes
|
4 |
2017 |
4
🐜
|
